The primary role of ERCP in the management of CCA is to provide palliation of obstructive jaundice in patients with a limited life expectancy. The aims of palliation are the relief of jaundice and ...

Oct. 13, 2003 — Magnetic resonance cholangiopancreatography (MRCP) has excellent overall sensitivity and specificity for the level and presence of obstruction, but it is less sensitive in detecting ...

BOSTON – Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used ...

At the 2021 Cholangiocarcinoma Foundation Annual Conference, experts discussed guidelines and real-world data for the management of urgent symptoms in patients with cholangiocarcinoma who have biliary ...

Natick, MA – Boston Scientific Corporation’s WallFlex® Biliary RX Fully Covered Stent has received Health Canada approval for the treatment of benign biliary strictures, which supplements its current ...

Endoscopic intervention has emerged to become the first line treatment for benign biliary strictures following liver transplantation. The current endoscopic approach involves repetitive dilatation of ...

Biliary stent migration represents a significant clinical challenge, occurring when stents inserted to relieve biliary obstructions dislodge from their intended positions. This phenomenon can lead to ...

Bile duct stents that stay in too long may cause complications. Experts differ on how long a bile duct stent should stay in, but most suggest removing or replacing it every 3 to 6 months. This can ...

NATICK, Mass., Boston Scientific Corporation has completed enrollment in a clinical trial to evaluate its WallFlex® Biliary RX Fully Covered Stent for the treatment of benign bile duct strictures ...